Haohai Biotech announced that on September 11, 2026, the company repurchased 24,300 H shares through the Hong Kong Stock Exchange. The repurchase price range for each share was HK$16.31 to HK$16.68. The total repurchase amount was HK$3,99,865, accounting for 0.0108% of the total number of H shares issued before the incident. The shares to be cancelled have not yet been cancelled. The share repurchase authorization for this repurchase was reviewed and approved on May 29, 2026. The total number of H shares authorized to be repurchased was 347,8034. As of the completion of the repurchase, a total of 831,800 H shares were repurchased through this authorization, accounting for 2.3916% of the total number of H shares issued on the date the authorization was approved.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.